Home/Filings/4/0001415889-24-002764
4//SEC Filing

VASCONCELLES MICHAEL 4

Accession 0001415889-24-002764

CIK 0000855654other

Filed

Feb 4, 7:00 PM ET

Accepted

Feb 5, 9:29 PM ET

Size

5.8 KB

Accession

0001415889-24-002764

Insider Transaction Report

Form 4
Period: 2024-02-01
VASCONCELLES MICHAEL
EVP R&D & MEDICAL AFFAIRS
Transactions
  • Award

    Restricted Stock Unit

    2024-02-01+50,51550,515 total
    Exercise: $0.00Common Stock (50,515 underlying)
Footnotes (2)
  • [F1]Each restricted stock unit ("RSU") represents the contingent right to receive, upon vesting of the RSU, one share of the Issuer's common stock.
  • [F2]The RSUs vest over a three-year period, with 33 1/3% of the RSUs vesting on each of the first three anniversaries of the date of grant, subject to continued service through each vesting date.

Issuer

ImmunoGen, Inc.

CIK 0000855654

Entity typeother

Related Parties

1
  • filerCIK 0001734755

Filing Metadata

Form type
4
Filed
Feb 4, 7:00 PM ET
Accepted
Feb 5, 9:29 PM ET
Size
5.8 KB